In a previous study, hsa-miR-30d has been already shown to be downregulated in thyroid carcinogenesis via targeting polycomb protein enhancer of zeste 2 (EZH2)24,25 and in squamous cell lung carcinoma23. Here, EZH2 is linked to thyroid gland disorder.